Relationship between the severity of obstructive sleep apnea and impaired glucose metabolism in patients with obstructive sleep apnea

Respiratory Medicine

Volumn 102, Issue 10, 2008, Pages 1412-1416

  Tamura, Akira ^a   Kawano, Yoshiyuki ^a   Watanabe, Toru ^b   Kadota, Junichi ^a  

^a OITA UNIVERSITY   (Japan)

^b Oita Nakamura Hospital   (Japan)

Author keywords

Apnea hypopnea index; Impaired glucose metabolism; Obstructive sleep apnea

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; STATIN;

ADULT; AGED; ARTICLE; BODY MASS; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; JAPANESE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; OXYGEN TENSION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SEX DIFFERENCE; SLEEP APNEA SYNDROME; UNIVARIATE ANALYSIS;

AGED; BODY COMPOSITION; BODY MASS INDEX; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; ODDS RATIO; POLYSOMNOGRAPHY; RISK FACTORS; SEX FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 50249086868     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.04.020     Document Type: Article

References (43)

1. Strohl K.P., Novak R.D., Singer W., Cahan C., Boehm K.D., Denko C.W., et al. Insulin levels, blood pressure and sleep apnea. Sleep 17 (1994) 614-618
2. Grunstein R.R., Stenlof K., Hedner J., and Sjostrom L. Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. Int J Obes Relat Metab Disord 19 (1995) 410-418
3. Stoohs R.A., Facchini F., and Guilleminault C. Insulin resistance and sleep-disordered breathing in healthy humans. Am J Respir Crit Care Med 154 (1996) 170-174
4. Strohl K.P. Diabetes and sleep apnea. Sleep 19 (1996) S225-S228
5. Ip M.S., Lam K.S., Ho C., Tsang K.W., and Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118 (2000) 580-586
6. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Hopper K., Lotsikas A., Lin H.M., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85 (2000) 1151-1158
7. Elmasry A., Lindberg E., Berne C., Janson C., Gislason T., Awad Tageldin M., et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 249 (2001) 153-161
8. Ip M.S., Lam B., Ng M.M., Lam W.K., Tsang K.W., and Lam K.S. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165 (2002) 670-676
9. Punjabi N.M., Sorkin J.D., Katzel L.I., Goldberg A.P., Schwartz A.R., and Smith P.L. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165 (2002) 677-682
10. Sanders M.H., and Givelber R. Sleep-disordered breathing may not be an independent risk factor for diabetes, but diabetes may contribute to the occurrence of periodic breathing in sleep. Sleep Med 4 (2003) 349-350
11. Gruber A., Horwood F., Sithole J., Ali N.J., and Idris I. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 5 (2006) 22
12. Meslier N., Gagnadoux F., Giraud P., Person C., Ouksel H., Urban T., et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 22 (2003) 156-160
13. Tominaga M., Eguchi H., Manaka H., Igarashi K., Kato T., and Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes study. Diabetes Care 22 (1999) 920-924
14. Kannel W.B., and McGee D.L. Diabetes and cardiovascular disease. The Framingham Study. JAMA 241 (1979) 2035-2038
15. Kannel W.B., and McGee D.L. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care 2 (1979) 120-126
16. Fujishima M., Kiyohara Y., Kato I., Ohmura T., Iwamoto H., Nakayama K., et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: the Hisayama Study. Diabetes 45 Suppl. (1996) S14-S16
17. Juutilainen A., Lehto S., Rönnemaa T., Pyörälä K., and Laakso M. Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects. Diabetes Care 28 (2005) 2901-2907
18. He J., Krygwe M.H., Zorick F.J., Conway W., and Roth T. Mortality and apnea index in obstructive sleep apnea: experience in 358 male patients. Chest 94 (1988) 9-14
19. Gonzalez-Rothi R.J., Foresman G.E., and Block A.J. Do patients with sleep apnea die in their sleep?. Chest 94 (1988) 531-538
20. Partinen M., Jamieson A., and Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients: mortality. Chest 94 (1988) 1200-1204
21. Lavie P., Herer P., Peled R., Berger I., Yoffe N., Zomer J., et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 18 (1995) 149-157
22. Ancoli-Israel S., Kripke D.F., Klauber M.R., Fell R., Stepnowsky C., Estline E., et al. Morbidity, mortality and sleep-disordered breathing in community dwelling elderly. Sleep 19 (1996) 277-282
23. Nieto F.J., Young T.B., Lind B.K., Shahar E., Samet J.M., Redline S., et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: the Sleep Heart Health Study. JAMA 283 (2000) 1829-1836
24. Shahar E., Whitney C.W., Redline S., Lee E.T., Newman A.B., Javier Nieto F., et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163 (2001) 19-25
25. Marin J.M., Carrizo S.J., Vincente E., and Agusti A.G.N. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365 (2005) 1046-1053
26. Dimsdale J.E., Coy T., Ziegler M.G., Ancoli-Israel S., and Clausen J. The effect of sleep apnea on plasma and urinary catecholamines. Sleep 18 (1995) 377-381
27. Somers V.K., Dyken M.E., Clary M.P., and Abboud F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96 (1995) 1897-1904
28. Leuenberger U., Jacob E., Sweer L., Waravdekar N., Zwillich C., and Sinoway L. Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol 79 (1995) 581-588
29. Waradekar N.V., Sinoway L.I., Zwillich C.W., and Leuenberger U.A. Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 153 (1996) 1333-1338
30. Dimsdale J.E., Coy T., Ancoli-Israel S., Clausen J., and Ziegler M.G. Sympathetic nervous system alterations in sleep apnea: the relative importance of respiratory disturbance, hypoxia, and sleep quality. Chest 111 (1997) 639-642
31. Leproult R., Copinschi G., Buxton O., and Van Cauter E. Sleep loss results in an elevation of cortisol levels the next evening. Sleep 20 (1997) 865-870
32. Spiegel K., Leproult R., and Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 354 (1999) 1435-1439
33. Vgontzas A.N., Pejovic S., Zoumakis E., Lin H.M., Bentley C.M., Bixler E.O., et al. Hypothalamic-pituitary-adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy. J Clin Endocrinol Metab 92 (2007) 4199-4207
34. Hjalmarsen A., Aasebø U., Birkeland K., Sager G., and Jorde R. Impaired glucose tolerance in patients with chronic hypoxic pulmonary disease. Diabetes Metab 22 (1996) 37-42
35. Cheng N., Cai W., Jiang M., and Wu S. Effect of hypoxia on blood glucose, hormones, and insulin receptor functions in newborn calves. Pediatr Res 41 (1997) 852-856
36. Larsen J.J., Hansen J.M., Olsen N.V., Galbo H., and Dela F. The effect of altitude hypoxia on glucose homeostasis in men. J Physiol (Lond) 504 (1997) 241-249
37. Raff H., Burder E.D., and Jankowski B.M. The effect of hypoxia on plasma leptin and insulin in newborn and juvenile rats. Endocrine 11 (1999) 37-39
38. 1-adrenergic blockade reduces insulin sensitivity. J Appl Physiol 91 (2001) 623-631
39. Ryan S., Taylor C.T., and McNicholas W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112 (2005) 2660-2667
40. Ryan S., Taylor C.T., and McNicholas W.T. Predictors of elevated nuclear factor-κB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 174 (2006) 824-830
41. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
42. Uysal K.T., Wiesbrock S.M., Marino M.W., and Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389 (1997) 610-614
43. Li K.K., Powell N.B., Kushida C., Riley R.W., Adornato B., and Guilleminault C. A comparison of Asian and White patients with obstructive sleep apnea syndrome. Laryngoscope 109 (1999) 1937-1940